Provimi Holding B.V. – Trademark Portfolio
Entity Type: 03
Provimi Holding B.V. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 31 (Natural Agricultural Products) — 10 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include PROVIMI and PROHACID. The owner is based in NL-3072 AN Rotterdam.
Veerlaan 17-23
NL-3072 AN Rotterdam , NL
Showing of trademarks Trademarks
Trademark Classifications
Provimi Holding B.V.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Provimi Holding B.V. have?
Provimi Holding B.V. has 12 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned, 2 cancelled.
What trademark classes does Provimi Holding B.V. file in?
Provimi Holding B.V. files trademarks across 3 Nice Classification classes. The most active classes are Class 31 (Natural Agricultural Products), Class 5 (Pharmaceuticals), Class 44 (Medical Services). Class 31 covers raw and unprocessed agricultural, aquacultural, horticultural and forestry products.
What are Provimi Holding B.V.'s most well-known trademarks?
Provimi Holding B.V.'s registered trademark portfolio includes well-known marks such as PROVIMI and PROHACID. These are among 3 currently registered trademarks in the portfolio.
What is Provimi Holding B.V.'s trademark registration success rate?
Provimi Holding B.V. has a 38% trademark registration rate, with 3 out of 8 resolved applications resulting in successful registration. Currently, 0 applications are pending review.